tiprankstipranks
Trending News
More News >
Dolby Laboratories (DLB)
NYSE:DLB

Dolby Laboratories (DLB) AI Stock Analysis

Compare
256 Followers

Top Page

DLB

Dolby Laboratories

(NYSE:DLB)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
$75.00
▲(13.96% Upside)
Dolby Laboratories' overall stock score reflects its strong financial performance and positive earnings call outlook, which are the most significant factors. The technical analysis suggests a neutral market position, while the valuation indicates a potential overvaluation. The company's strategic focus on expanding its advanced audio and visual products supports a positive long-term outlook.
Positive Factors
Revenue Growth
The 6% revenue growth, supported by strategic acquisitions, indicates a strong market position and potential for sustained future growth.
Product Innovation
The launch of Dolby Vision 2 highlights Dolby's commitment to innovation, enhancing its competitive edge in the imaging technology market.
Automotive Market Expansion
Expanding into the automotive sector with major brands increases Dolby's market reach and diversifies its revenue streams.
Negative Factors
Foundational Audio Revenue Decline
Declining revenue in foundational audio technology could indicate challenges in maintaining market share in core segments.
Consumer Electronics Decline
A decline in consumer electronics and PCs suggests potential headwinds in these markets, impacting overall revenue growth.
Q1 Fiscal 2026 Revenue Guidance
Projected revenue decline in Q1 2026 indicates potential short-term challenges, affecting near-term financial performance.

Dolby Laboratories (DLB) vs. SPDR S&P 500 ETF (SPY)

Dolby Laboratories Business Overview & Revenue Model

Company DescriptionDolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications.; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, an digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and a range of media devices. Its audio technologies also include Dolby Digital, a digital audio coding technology that provides multichannel sound to applications; Dolby Digital Plus, a digital audio coding technology that offers audio transmission for a range of media applications and devices; Dolby TrueHD, a digital audio coding technology providing encoding for media application; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio conferencing technology; and HEVC, a digital video codec with high bandwidth efficiency to support for media devices. In addition, the company designs and manufactures digital cinema servers, cinema processors, amplifiers, loudspeakers, hardware components, video conferencing solutions, and other products for the cinema, television, broadcast, communication, and entertainment industries. Further, it offers various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
How the Company Makes MoneyDolby Laboratories generates revenue primarily through licensing its technologies to a wide range of partners in the entertainment and technology sectors. Key revenue streams include licensing fees from film studios, television networks, and streaming services that utilize Dolby's audio and video technologies in their productions. Additionally, Dolby earns income from partnerships with consumer electronics manufacturers who integrate Dolby technologies into their products, such as TVs, sound systems, and smartphones. The company also engages in the sale of products and services related to its technologies, including software tools and consulting services for content creators. Significant factors contributing to its earnings include the growing demand for high-quality audio and video experiences, the expansion of streaming services, and collaborations with key industry players, enhancing Dolby's market presence and revenue potential.

Dolby Laboratories Key Performance Indicators (KPIs)

Any
Any
Remaining Performance Obligations
Remaining Performance Obligations
Represents the value of contracted revenue yet to be recognized, offering insight into future revenue streams and business stability.
Chart InsightsDolby Laboratories' Remaining Performance Obligations saw a significant spike in late 2023, followed by a gradual decline into 2025. This trend aligns with the company's strong licensing revenue and adoption of Dolby Atmos, as highlighted in their earnings call. However, the decline in the Consumer Electronics segment and macroeconomic uncertainties could pose risks to sustaining this momentum. Despite these challenges, Dolby remains optimistic about long-term growth, driven by strategic partnerships and increasing demand for its technologies across various markets.
Data provided by:The Fly

Dolby Laboratories Earnings Call Summary

Earnings Call Date:Nov 18, 2025
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Jan 29, 2026
Earnings Call Sentiment Neutral
Dolby Laboratories reported solid revenue growth and operating margin expansion, with strong engagement in their Dolby Atmos and Vision products across various sectors. However, there were challenges with foundational audio technology and certain market segments showing decline. The overall sentiment is balanced, with significant forward-looking opportunities alongside current market challenges.
Q4-2025 Updates
Positive Updates
Revenue Growth and Operating Margin Expansion
In FY 2025, Dolby Laboratories grew revenue by 6%, aided by the acquisition of GE Licensing, and expanded their operating margins by 1.8 percentage points.
Strong Engagement with Dolby Atmos and Dolby Vision
Dolby continues to see strong engagement from content creators, distributors, and device OEMs with Dolby Atmos and Dolby Vision across sports, music, TV, and movies.
Launch of Dolby Vision 2
Dolby Vision 2 was announced, promising improved picture quality with features like ambient light detection and motion control, receiving strong industry reception.
Automotive Expansion
Dolby Atmos and Vision are being integrated into vehicles by brands such as Maruti Suzuki, Li Auto, and Mercedes, expanding Dolby's presence in the automotive sector.
Growth in Mobile and Wearables
Instagram and Douyin have started distributing content in Dolby Vision, and Meta Quest and Samsung Galaxy XR now feature Dolby Atmos and Vision.
Imaging Patents Expansion
Dolby launched a new patent pool for streaming providers, significantly expanding the total addressable market for imaging patents.
Negative Updates
Foundational Audio Technology Revenue Decline
Revenue from Foundational Audio Technology came in just under negative 1%, aligning with expectations of flat growth.
Decline in Consumer Electronics and PCs
Consumer electronics and PCs saw a high single-digit decline, attributed to lower expected unit shipments.
Q1 Fiscal 2026 Revenue Guidance
Q1 2026 revenue is expected to decline approximately 8% year-over-year at the midpoint, due to a tough comparison and timing of recoveries and commitments.
Restructuring Costs
A $6 million restructuring charge was recorded as Dolby continues to streamline operations.
Company Guidance
During the Dolby Laboratories' Fourth Quarter Fiscal Year 2025 earnings call, the company provided guidance for Fiscal Year 2026, projecting revenue between $1.39 billion and $1.44 billion, reflecting an increase of 3% to 7% year-over-year. Licensing revenue is expected to be between $1.285 billion and $1.335 billion, with Dolby Atmos, Dolby Vision, and imaging patents projected to grow approximately 15%. Non-GAAP operating expenses are anticipated to range from $780 million to $800 million, with an improvement in operating margins by 50 to 100 basis points. The company also expects non-GAAP earnings per share between $4.19 and $4.34. For the first quarter of Fiscal Year 2026, revenue guidance is set between $315 million and $345 million, with licensing revenue anticipated to be between $290 million and $320 million. The company aims for a gross margin of approximately 90% on a non-GAAP basis, with non-GAAP earnings per share estimated between $0.79 and $0.94. Factors influencing the first quarter include a challenging comparison to 2025 and the timing of recoveries and minimum volume commitments.

Dolby Laboratories Financial Statement Overview

Summary
Dolby Laboratories presents a strong financial position with robust revenue growth, efficient cost management, and solid cash flow generation. While the net profit margin and return on equity have shown some decline, the company's low leverage and strong equity base provide a stable foundation for future growth.
Income Statement
75
Positive
Dolby Laboratories shows a stable revenue growth rate of 2.19% in the latest year, recovering from a slight decline in previous years. The gross profit margin remains strong at 88.13%, indicating efficient cost management. However, the net profit margin has slightly decreased to 18.90% from 20.56% in the previous year, suggesting some pressure on net profitability. Overall, the income statement reflects a solid performance with room for improvement in net profitability.
Balance Sheet
80
Positive
The company maintains a healthy balance sheet with a low debt-to-equity ratio, indicating minimal leverage risk. The equity ratio is strong, reflecting a solid capital structure. However, the return on equity has decreased to 0%, which could be a concern if it persists. Overall, the balance sheet is robust, with a strong equity base and low debt levels.
Cash Flow
78
Positive
Dolby Laboratories has shown a significant improvement in free cash flow growth at 10.20%, indicating strong cash generation capabilities. The operating cash flow to net income ratio is not available, but the free cash flow to net income ratio suggests efficient cash management. Overall, the cash flow statement reflects a positive cash flow trajectory, supporting the company's financial stability.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.35B1.35B1.27B1.30B1.25B1.28B
Gross Profit1.19B1.19B1.13B1.15B1.11B1.15B
EBITDA387.80M378.56M399.81M345.57M318.89M450.37M
Net Income255.02M255.02M261.82M200.66M184.09M310.23M
Balance Sheet
Total Assets3.23B3.23B3.13B2.99B2.70B3.12B
Cash, Cash Equivalents and Short-Term Investments702.60M702.60M577.75M957.11M817.58M1.27B
Total Debt38.88M38.88M46.99M50.65M50.94M72.12M
Total Liabilities595.81M595.81M643.72M622.38M451.15M518.66M
Stockholders Equity2.62B2.62B2.48B2.36B2.25B2.60B
Cash Flow
Free Cash Flow430.26M430.26M297.25M336.74M259.12M393.30M
Operating Cash Flow472.20M472.20M327.25M367.08M318.58M447.75M
Investing Cash Flow-10.59M-10.59M-286.29M54.21M-295.94M-44.91M
Financing Cash Flow-247.24M-247.24M-287.81M-236.81M-610.56M-252.51M

Dolby Laboratories Technical Analysis

Technical Analysis Sentiment
Negative
Last Price65.81
Price Trends
50DMA
66.51
Negative
100DMA
69.13
Negative
200DMA
72.15
Negative
Market Momentum
MACD
0.03
Positive
RSI
45.95
Neutral
STOCH
15.86
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DLB, the sentiment is Negative. The current price of 65.81 is below the 20-day moving average (MA) of 66.87, below the 50-day MA of 66.51, and below the 200-day MA of 72.15, indicating a bearish trend. The MACD of 0.03 indicates Positive momentum. The RSI at 45.95 is Neutral, neither overbought nor oversold. The STOCH value of 15.86 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DLB.

Dolby Laboratories Risk Analysis

Dolby Laboratories disclosed 13 risk factors in its most recent earnings report. Dolby Laboratories reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Dolby Laboratories Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$41.22B19.8014.50%1.46%7.44%-4.57%
79
Outperform
$179.80B22.5125.35%2.25%6.58%1.19%
78
Outperform
$26.38B28.9038.21%1.63%8.57%35.02%
76
Outperform
$74.19B25.6229.15%2.50%4.62%1.06%
74
Outperform
$6.33B25.3210.00%2.04%5.92%-2.98%
67
Neutral
$18.07B21.96109.26%5.24%-16.05%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DLB
Dolby Laboratories
66.24
-10.63
-13.83%
ACN
Accenture
270.67
-83.56
-23.59%
BR
Broadridge Financial Solutions
228.22
4.42
1.97%
CTSH
Cognizant
85.21
6.99
8.94%
IT
Gartner
250.46
-239.50
-48.88%
INFY
Infosys
19.16
-3.05
-13.73%

Dolby Laboratories Corporate Events

Product-Related AnnouncementsBusiness Operations and StrategyFinancial Disclosures
Dolby Laboratories Reports Strong Q4 2025 Financial Results
Positive
Nov 18, 2025

On November 18, 2025, Dolby Laboratories announced its financial results for the fourth quarter and fiscal year 2025, reporting a total revenue of $307 million for the quarter and $1.35 billion for the year. The company highlighted growth in its Dolby Atmos and Dolby Vision technologies, as well as new partnerships and product launches, indicating a strong market position as it heads into fiscal year 2026.

Executive/Board Changes
Dolby Laboratories Approves 2026 Executive Bonus Plan
Neutral
Nov 14, 2025

On November 11, 2025, Dolby Laboratories‘ Compensation Committee approved the 2026 Executive Bonus Plan, targeting executive officers with bonuses based on a percentage of their base salary. The plan emphasizes achieving non-GAAP operating income and revenue goals, with potential adjustments by the Committee, impacting the final bonus amounts for executives.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 09, 2025